順鑫農業(000860.SZ):擬設河北順鑫小店畜牧發展 完善生豬養殖業務佈局
格隆匯9月15日丨順鑫農業(000860.SZ)公佈,公司擬設立河北順鑫小店畜牧發展有限公司(“新公司”),註冊資本2000萬元。
此次對外投資的目的是深入貫徹國家鼓勵生豬產業發展的相關政策,完善公司生豬養殖業務佈局,掌控自有生豬資源供應。公司通過設立新公司,增強產業鏈上游生豬的供應保障能力,為公司下一步拓展生豬養殖產能,促進種豬品種的更新迭代,積累種源優勢,實現公司生豬產業的可持續發展。
新公司設立後,將納入公司合併報表範圍內,利於強化公司豬肉產業核心競爭力,滿足公司產業一體化發展的需要,有利於公司的長期穩定和可持續發展,不會對公司主營業務造成不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.